PsyBio Therapeutics Pink Sheet Forecast - Double Exponential Smoothing

PSYBF Stock  USD 0.0001  0.00  0.00%   
The Double Exponential Smoothing forecasted value of PsyBio Therapeutics Corp on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.0007 and the sum of the absolute errors of 0.04. PsyBio Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of PsyBio Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for PsyBio Therapeutics works best with periods where there are trends or seasonality.

PsyBio Therapeutics Double Exponential Smoothing Price Forecast For the 30th of November

Given 90 days horizon, the Double Exponential Smoothing forecasted value of PsyBio Therapeutics Corp on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.0007, mean absolute percentage error of 0.00000826, and the sum of the absolute errors of 0.04.
Please note that although there have been many attempts to predict PsyBio Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that PsyBio Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

PsyBio Therapeutics Pink Sheet Forecast Pattern

Backtest PsyBio TherapeuticsPsyBio Therapeutics Price PredictionBuy or Sell Advice 

PsyBio Therapeutics Forecasted Value

In the context of forecasting PsyBio Therapeutics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. PsyBio Therapeutics' downside and upside margins for the forecasting period are 0.000001 and 126.29, respectively. We have considered PsyBio Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0001
0.000001
Downside
0.0001
Expected Value
126.29
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of PsyBio Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent PsyBio Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors None
MADMean absolute deviation7.0E-4
MAPEMean absolute percentage error2.6738
SAESum of the absolute errors0.0418
When PsyBio Therapeutics Corp prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any PsyBio Therapeutics Corp trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent PsyBio Therapeutics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for PsyBio Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PsyBio Therapeutics Corp. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00009350.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.00009650.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as PsyBio Therapeutics. Your research has to be compared to or analyzed against PsyBio Therapeutics' peers to derive any actionable benefits. When done correctly, PsyBio Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in PsyBio Therapeutics Corp.

Other Forecasting Options for PsyBio Therapeutics

For every potential investor in PsyBio, whether a beginner or expert, PsyBio Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. PsyBio Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in PsyBio. Basic forecasting techniques help filter out the noise by identifying PsyBio Therapeutics' price trends.

PsyBio Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PsyBio Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of PsyBio Therapeutics could also be used in its relative valuation, which is a method of valuing PsyBio Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

PsyBio Therapeutics Corp Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of PsyBio Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of PsyBio Therapeutics' current price.

PsyBio Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how PsyBio Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PsyBio Therapeutics shares will generate the highest return on investment. By undertsting and applying PsyBio Therapeutics pink sheet market strength indicators, traders can identify PsyBio Therapeutics Corp entry and exit signals to maximize returns.

PsyBio Therapeutics Risk Indicators

The analysis of PsyBio Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in PsyBio Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting psybio pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Other Information on Investing in PsyBio Pink Sheet

PsyBio Therapeutics financial ratios help investors to determine whether PsyBio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PsyBio with respect to the benefits of owning PsyBio Therapeutics security.